A Study on the Bioequivalence of Bupivacaine Liposome Injection in Humans

NCT07279155 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Postoperative Local Analgesia

Interventions

DRUG: Bupivacaine Liposome Injection T preparation
DRUG: Bupivacaine Liposome Injection R preparation

Sponsor

Jiangsu HengRui Medicine Co., Ltd.